PET Imaging Expedites Detection of Aberration in the Humanization of an Annexin A1 Targeting Antibody
<b>Objectives</b>: Annexin-A1 is a 37 kDa phospholipid-binding protein which is concentrated in a truncated 34 kDa form (AnnA1) in caveolae on the tumor vascular endothelial cell surface with expression in many tumor types. PRISM developed the monoclonal mouse antibody mAnnA1 against Ann...
Saved in:
| Main Authors: | Hailey A. Houson, Brian D. Wright, Solana R. Fernandez, Tim Buss, Sharon L. White, Brittany Cederstrom, James M. Omweri, Jonathan E. McConathy, Jan E. Schnitzer, Suzanne E. Lapi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/3/295 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radiation protection considerations with [89Zr]Zr-girentuximab PET and surgery
by: Adnan Chowdhury, et al.
Published: (2025-05-01) -
Phantom-based investigation of block sequential regularised expectation maximisation (BSREM) reconstruction for zirconium-89 PET-CT for varied count levels
by: Lara M. Bonney, et al.
Published: (2025-02-01) -
Intracellular Protein Binding of Zr-89 Oxine Cell Labeling for PET Cell Tracking Studies
by: Emmanuel Nyong, et al.
Published: (2025-04-01) -
Detection of immune-mediated tumour cell death in vivo using Zirconium-89-labeled APOMAB®
by: Vasilios Liapis, et al.
Published: (2025-06-01) -
<sup>89</sup>Zr-Radiolabelling of p-NCS-Bz-DFO-Anti-HER2 Affibody Immunoconjugate: Characterization and Assessment of In Vitro Potential in HER2-Positive Breast Cancer Imaging
by: Maria-Roxana Tudoroiu-Cornoiu, et al.
Published: (2025-06-01)